Watch KLRA. Know when insiders buy.
One email the day a filing lands. Free.
KLRA
Kailera Therapeutics, Inc.
12.89
+1.46 +12.77%
USD · close Oct 20
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
68
PASS · shorts 68
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
1 / 15
tracked funds hold it
Calls on record
0
nobody we score has called it yet
FINANCIALS: NOT YET PULLED FROM SEC XBRL, CHECK BACK AFTER TONIGHT52W 10.00 – 26.00
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | — | — | — | −$121.4M | −$111.3M | — | -1.09 | −$77.5M | — | — | Aug 12 |
| Q1 2026 · Mar 31 | — | — | — | −$84.7M | −$78.9M | — | -3650.00 | −$68.3M | — | — | Aug 12 |
| Q2 2025 · Jun 30 | — | — | — | −$30.7M | −$28.9M | — | -28947.00 | −$26.2M | — | — | Aug 12 |
| Q1 2025 · Mar 31 | — | — | — | −$20.5M | −$18M | — | -17983.00 | −$18.2M | — | — | Aug 12 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|
Every number comes from Kailera Therapeutics, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.